e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Cell biology of lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
CD146 in the pathogenesis of COPD
A. Kratzer, J. Salys, H. W. Chu, M. Zamora, L. Taraseviciene-Stewart (Denver, United States Of America)
Source:
Annual Congress 2011 - Cell biology of lung disease
Session:
Cell biology of lung disease
Session type:
Thematic Poster Session
Number:
3892
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Kratzer, J. Salys, H. W. Chu, M. Zamora, L. Taraseviciene-Stewart (Denver, United States Of America). CD146 in the pathogenesis of COPD. Eur Respir J 2011; 38: Suppl. 55, 3892
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The involvement of thrombospondin-1 in COPD pathogenesis through IL-8 production
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
M2 macrophage marker CD163, CD204 and CD206 expression on alveolar macrophages in the lung of patients with chronic obstructive pulmonary
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
PP108 – Role of TRIM-16-mediated lysophagy in COPD pathogenesis
Source: ERS Lung Science Conference 2021
Year: 2021
PARK2-regulated mitophagy in COPD pathogenesis
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017
Reduced expression of CD44 on lung macrophages from patients with COPD
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Periostin as a marker of Th2-related inflammation in patients with different types of chronic obstructive airway disease
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
DPP10 protein expression is associated with the pathogenesis of asthma and COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 231s
Year: 2005
Periostin levels in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function
Source: Eur Respir J 2006; 28: 113-122
Year: 2006
Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Expression of CD38 and its participation in formation of endothelial dysfunction in patients with bronchial asthma
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Role of low-grade inflammation markers and soluble cell adhesion molecules in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
Circulating adhesion molecules in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 316s
Year: 2004
The role of CX3CL1 and ADAM17 in pathogenesis of diffuse parenchymal lung diseases
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
Low circulating CD34+ cells in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 362s
Year: 2005
The relationship between bronchial inflammation and markers of disease progression in COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 179s
Year: 2003
Espression of clusterin and CD44 in bronchial biopsies of subjects with asthma and COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 321s
Year: 2004
Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 3-5
Year: 2004
Investigation of the role of miRNAs as a biomarker in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - COPD inflammation and genes
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept